General Information of Drug (ID: DMW0HBJ)

Drug Name
Dilanubicel
Synonyms NLA101
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
DS01GZ

References

1 ClinicalTrials.gov (NCT03301597) NLA101 in Adults Receiving High Dose Chemotherapy for AML (LAUNCH). U.S. National Institutes of Health.